scholarly journals Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer

1998 ◽  
Vol 77 (12) ◽  
pp. 2257-2263 ◽  
Author(s):  
M Bontenbal ◽  
◽  
M Andersson ◽  
J Wildiers ◽  
G Cocconi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Advanced Breast ◽  
Second Line ◽  
Randomized Phase Ii

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

2010 ◽  
Vol 30 (2) ◽  
pp. 681-687 ◽  
Author(s):  
Katalin Boér ◽  
István Láng ◽  
Antonio Llombart-Cussac ◽  
Inger Andreasson ◽  
Guillermo L. Vivanco ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Randomized Phase Ii

scholarly journals A phase II study of carboplatin and vinorelbine as second-line treatment for advanced breast cancer

1995 ◽  
Vol 72 (5) ◽  
pp. 1256-1258 ◽  
Author(s):  
RV Iaffaioli ◽  
A Tortoriello ◽  
G Facchini ◽  
M Santangelo ◽  
G De Sena ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Line Treatment ◽  
Second Line
Sign in / Sign up

Export Citation Format

Share Document